Jayashankar, Vaishali
Kubiniok, Peter
McCracken, Alison N
Gentry, Rebeca G
Eckenstein, Kazumi H
Sernissi, Lorenzo https://orcid.org/0000-0003-2604-1663
Vece, Vito
Garsi, Jean-Baptiste
Valles, Sarah Y https://orcid.org/0009-0000-7593-1270
Jung, Sunhee https://orcid.org/0000-0001-5396-4813
Hoffman, Natalie C
Perrochon, Arielle S
Selwan, Elizabeth M
Finicle, Brendan T
Pitman, Mary
Lin, DaWei
Bonneil, Éric
Xu, Ruijuan
Mao, Cungui
Kaiser, Peter https://orcid.org/0000-0002-3326-0090
Fruman, David A
Mobley, David
Jang, Cholsoon
Hanessian, Stephen https://orcid.org/0000-0003-3582-6972
Thibault, Pierre https://orcid.org/0000-0001-5993-0331
Edinger, Aimee L https://orcid.org/0000-0003-4277-4584
Funding for this research was provided by:
HHS | NIH | National Institute of General Medical Sciences (R01 GM089919)
HHS | NIH | National Institute of General Medical Sciences (R35GM148350)
HHS | NIH | National Cancer Institute (R01 CA254360)
HHS | NIH | National Cancer Institute (R21 CA178230)
HHS | NIH | National Cancer Institute (T32 CA009054)
HHS | NIH | National Cancer Institute (P30 CA062203)
American Cancer Society (RSG-11-111-01-CDD)
DOD | MHS | CDMRP | DOD Peer Reviewed Cancer Research Program (BC14027)
Ono Pharma Foundation (G-1902-0039)
American Diabetes Association (11-23-PDF-03)
National Research Foundation of Korea (2021R1A6A3A-14039681)
Canadian Government | Natural Sciences and Engineering Research Council of Canada
Institute for Research in Immunology and Cancer
Canadian Foundation for Innovation
Fonds de Recherche du Québec - Santé
Genome Canada
Genome Québec
UC Irvine Anticancer Challenge
UC Irvine Applied Innovation
Article History
Received: 18 April 2025
Revised: 18 May 2025
Accepted: 27 May 2025
First Online: 30 June 2025
Disclosure and competing interests statement
: ALE and SH are inventors on a patent covering SH-BC-893. Other authors declare no competing interests. ALE, PT, and SH are co-corresponding authors. Requests for biological materials should be directed to ALE.